Targeting Bruton Tyrosine Kinase: A novel strategy in the treatment of B-cell lymphomas

Publicado en línea: 30 jun 2017

Páginas: 7 - 14

Recibido: 08 sept 2016

Aceptado: 24 ago 2017

DOI: https://doi.org/10.1515/fco-2015-0026

Palabras clave

Bruton, tyrosine, kinase, inhibitor, ibrutinib, BCR, lymphoma, CLL, treatment

© 2017 Sklavenitis-Pistofidis R., Koletsa T., Lazaridou A., Goulas A.

This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.